Fifth Third Bancorp’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $508K | Buy |
53,976
+53,558
| +12,813% | +$588K | ﹤0.01% | 2035 |
|
|
2025
Q4 | $5.19K | Sell |
418
-40
| -9% | -$532 | ﹤0.01% | 2295 |
|
|
2025
Q3 | $6.56K | Buy |
458
+63
| +16% | +$863 | ﹤0.01% | 2261 |
|
|
2025
Q2 | $4.85K | Sell |
395
-21
| -5% | -$305 | ﹤0.01% | 2198 |
|
|
2025
Q1 | $9.15K | Buy |
416
+139
| +50% | +$3.27K | ﹤0.01% | 2039 |
|
|
2024
Q4 | $6.28K | Buy |
277
+79
| +40% | +$1.72K | ﹤0.01% | 2106 |
|
|
2024
Q3 | $3.6K | Sell |
198
-178
| -47% | -$4.13K | ﹤0.01% | 2257 |
|
|
2024
Q2 | $11K | Buy |
376
+167
| +80% | +$4.95K | ﹤0.01% | 1902 |
|
|
2024
Q1 | $7.41K | Sell |
209
-210
| -50% | -$8.4K | ﹤0.01% | 1954 |
|
|
2023
Q4 | $18.2K | Buy |
419
+46
| +12% | +$1.81K | ﹤0.01% | 1788 |
|
|
2023
Q3 | $14.2K | Sell |
373
-25
| -6% | -$1.05K | ﹤0.01% | 1851 |
|
|
2023
Q2 | $16.4K | Sell |
398
-5
| -1% | -$241 | ﹤0.01% | 1809 |
|
|
2023
Q1 | $23.1K | Sell |
403
-228
| -36% | -$12.8K | ﹤0.01% | 1769 |
|
|
2022
Q4 | $35.4K | Buy |
631
+183
| +41% | +$9.31K | ﹤0.01% | 1480 |
|
|
2022
Q3 | $19K | Sell |
448
-62
| -12% | -$3.18K | ﹤0.01% | 1705 |
|
|
2022
Q2 | $28K | Buy |
510
+79
| +18% | +$4.74K | ﹤0.01% | 1594 |
|
|
2022
Q1 | $28K | Buy |
431
+59
| +16% | +$3.88K | ﹤0.01% | 1683 |
|
|
2021
Q4 | $25K | Buy |
372
+102
| +38% | +$6.9K | ﹤0.01% | 1776 |
|
|
2021
Q3 | $18K | Buy |
270
+16
| +6% | +$1.13K | ﹤0.01% | 1822 |
|
|
2021
Q2 | $17K | Buy |
254
+40
| +19% | +$2.83K | ﹤0.01% | 1845 |
|
|
2021
Q1 | $15K | Buy |
214
+74
| +53% | +$5.01K | ﹤0.01% | 1877 |
|
|
2020
Q4 | $9K | Buy |
140
+110
| +367% | +$5.92K | ﹤0.01% | 1967 |
|
|
2020
Q3 | $1K | Sell |
30
-1,611
| -98% | -$76.6K | ﹤0.01% | 2166 |
|
|
2020
Q2 | $77K | Buy |
1,641
+266
| +19% | +$13.1K | ﹤0.01% | 1178 |
|
|
2020
Q1 | $61K | Buy |
1,375
+172
| +14% | +$9.03K | ﹤0.01% | 1215 |
|
|
2019
Q4 | $70K | Buy |
1,203
+196
| +19% | +$11.7K | ﹤0.01% | 1292 |
|
|
2019
Q3 | $60K | Buy |
1,007
+91
| +10% | +$5.42K | ﹤0.01% | 1287 |
|
|
2019
Q2 | $51K | Buy |
+916
| New | +$47.2K | ﹤0.01% | 1339 |
|
|
2018
Q4 | – | Sell |
-195
| Closed | -$13K | – | 2281 |
|
|
2018
Q3 | $13K | Sell |
195
-169
| -46% | -$10.5K | ﹤0.01% | 1760 |
|
|
2018
Q2 | $23K | Sell |
364
-44
| -11% | -$2.73K | ﹤0.01% | 1619 |
|
|
2018
Q1 | $23K | Hold |
408
| – | – | ﹤0.01% | 1609 |
|
|
2017
Q4 | $20K | Sell |
408
-1,244
| -75% | -$60.9K | ﹤0.01% | 1609 |
|
|
2017
Q3 | $83K | Buy |
1,652
+411
| +33% | +$21.1K | ﹤0.01% | 1127 |
|
|
2017
Q2 | $68K | Buy |
1,241
+1,137
| +1,093% | +$54.3K | ﹤0.01% | 1187 |
|
|
2017
Q1 | $4K | Buy |
104
+44
| +73% | +$1.88K | ﹤0.01% | 1888 |
|
|
2016
Q4 | $3K | Buy |
+60
| New | +$2.44K | ﹤0.01% | 2000 |
|
|
2016
Q1 | – | Sell |
-362
| Closed | -$12K | – | 2479 |
|
|
2015
Q4 | $12K | Buy |
362
+92
| +34% | +$2.88K | ﹤0.01% | 1870 |
|
|
2015
Q3 | $8K | Buy |
270
+157
| +139% | +$4.91K | ﹤0.01% | 2109 |
|
|
2015
Q2 | $3K | Buy |
113
+3
| +3% | +$80 | ﹤0.01% | 2439 |
|
|
2015
Q1 | $3K | Buy |
+110
| New | +$2.6K | ﹤0.01% | 2361 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Fifth Third Bancorp's IART Position: Q1 2026 in Review
Fifth Third Bancorp increased its Integra LifeSciences (IART) stake by 12,813% in Q1 2026, buying an estimated $588K and bringing the position to 53,976 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #2035.
Fifth Third Bancorp first reported a position in IART in Q1 2015 and has held it in 40 quarters since. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Fifth Third Bancorp held 53,976 shares of Integra LifeSciences worth $508K as of Q1 2026.
- Fifth Third Bancorp bought 53,558 Integra LifeSciences shares in Q1 2026, an estimated $588K.
- Integra LifeSciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #2035 holding.
- Fifth Third Bancorp first reported a position in Integra LifeSciences in Q1 2015 and has held it in 40 quarters since.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.